Lv2
110 积分 2024-01-30 加入
Efficacy and Safety of Surufatinib for Recurrent or Metastatic Malignant Salivary Gland Tumors: An Open-Label, Single-Arm, Phase II Study
8天前
已关闭
The Prognostic Value of Preoperative Serum CEA and CA19-9 Values in Stage I-III Colorectal Cancer
1个月前
已关闭
Once-daily savolitinib in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small-cell lung cancers harbouring MET exon 14 skipping alterations: a multicentre, single-arm, open-label, phase 2 study
3个月前
已完结
Dasatinib-Associated Creatine Kinase Level Elevation
3个月前
已完结
Elevated serum creatine kinase levels due to osimertinib: A case report and review of the literature
3个月前
已完结
From CHRYSALIS to PAPILLON: the metamorphosis of amivantamab into frontline therapy for NSCLC
3个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
3个月前
已完结
Emerging treatment landscape of non-muscle invasive bladder cancer
4个月前
已完结
Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial
4个月前
已完结
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
4个月前
已完结
皖公网安备34019202002308
